Prenetics Global Limited PRENW
Annual
Quarterly
FY2024 · ended Dec 31, 2024 · Revenue $30.62M, +40.8% YoY · Filed Apr 30, 2025
Prenetics Global Limited (PRE) files with the SEC under industry code 2834, Pharmaceutical Preparations. In fiscal 2024, which ended Dec 31, 2024, it reported revenue of $30.6 million and a net loss of $49.8 million. Free cash flow was -$29.9 million. As of Dec 31, 2024 it held $52.3 million in cash and investments and $5.8 million in total debt.
Revenue
$30.62M
+40.8% vs prior year
Net income
$-49.81M
+23.1% vs prior year
Operating cash flow
$-28.87M
-109.8% vs prior year
Free cash flow
$-29.88M
-111.8% vs prior year
EPS
$-3.71
+33.5% vs prior year
Dividend per share
None
Shares outstanding
16.87M
+30.0% vs prior year
Net cash
$46.48M
FY 2024
Operating margin
-157.2%
FY 2024
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- PRE (Nasdaq), PRENW (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- Cayman Islands
- Headquarters
- Quarry Bay, Hong Kong
- SEC filer status
- Non-accelerated filer, Emerging growth company
- SEC CIK
- 1876431
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2024 Dec 31, 2024 |
FY 2023 Dec 31, 2023 |
FY 2022 Dec 31, 2022 |
|---|---|---|---|
| Revenue | $30.6M | $21.7M | $13.2M |
| Operating income | -$48.1M | -$51.9M | -$66.0M |
| Net income | -$49.8M | -$64.8M | -$190.5M |
| Diluted EPS | -$3.71 | -$5.58 | -$37.57 |
| Operating cash flow | -$28.9M | -$13.8M | $14.5M |
| Free cash flow | -$29.9M | -$14.1M | $9.6M |
| Total assets | $213.6M | $254.2M | $312.1M |
| Total liabilities | $42.2M | $44.0M | $68.7M |
| Stockholders' equity | $171.3M | $210.2M | $243.5M |
| Cash and investments | $52.3M | $45.7M | $146.7M |
| Total debt | $5.8M | $2.4M | $6.6M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 6-K | Current report (foreign issuer) | Nov 5, 2026 | Nov 5, 2026 |
| 6-K | Current report (foreign issuer) | Nov 3, 2026 | Nov 3, 2026 |
| 6-K | Current report (foreign issuer) | Nov 2, 2026 | Oct 30, 2026 |
| 6-K | Current report (foreign issuer) | Oct 13, 2026 | Oct 12, 2026 |
| 20-F/A | Amended annual report (foreign issuer) | Sep 4, 2026 | Dec 31, 2025 |
| 6-K | Current report (foreign issuer) | Aug 26, 2026 | Aug 26, 2026 |
All 271 Prenetics Global Limited SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.